
News|Articles|December 1, 2012
Pipeline Preview
Recent FDA action (through November 2012) related to, H5N1 adjuvanted influenza vaccine, Pasireotide, Digoxin immune fab, Etirinotecan pegol, OBI-1, beclomethasone 17, 21-dipropionate, Regorafenib, Trastuzumab emtansine, A4250, Sildenafil
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Amivantamab, chemo combo shows nearly 3-year survival in EGFR exon 20 lung cancer
4
Anne Mall, M.H.A., on automating prior authorization approval requests | PBMI 2026
5
























